Cancer Family
Malignant Bone Marrow Neoplasm
CI-CAN-00000226Explore in graph →
1,034 active trials28 approved drugs633 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000226Explore in graph →
Clinical trials
4,609 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (799)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05563207 | Application of Health Education Path of Traditional Chinese Medicine Nursin | completed | N/A | 60 | Shijiazhuang Pingan HospitalOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05488717 | The Effect of Art-Based Mandala on Mental Health in Bone Marrow Transplant Patients | completed | N/A | 46 | Aysenur UcerizOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT03035422 |
| Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia(SET-HAPLO) |
| completed |
| N/A |
| 24 |
| Association for Training, Education, and Research in Hematology, Immunology, and TransplantationOTHER |
| 1 |
| Jul 25, 2022 |
| clinicaltrials |
| NCT02551718 | High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia | completed | N/A | 34 | University of WashingtonOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT02842320 | Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML)(CAR-LMC) | completed | N/A | 53 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT03429387 | PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia(PIPPIN) | completed | N/A | 147 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT00426205 | GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies | completed | N/A | 28 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT04039100 | Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease | completed | N/A | 43 | Rigshospitalet, DenmarkOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT04158726 | Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia | completed | N/A | 47 | Carevive Systems, Inc.INDUSTRY | 1 | Jan 18, 2022 | clinicaltrials |
| NCT00038675 | Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate | completed | N/A | 125 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT02592447 | Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention | completed | N/A | 48 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT03881826 | Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia(MicroAML) | completed | N/A | 60 | Université Catholique de LouvainOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT02559557 | Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects | completed | N/A | 38 | City of Hope Medical CenterOTHER | 1 | Aug 12, 2021 | clinicaltrials |
| NCT00988013 | Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies(IM-TMI) | completed | N/A | 14 | University of Illinois at ChicagoOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT01768845 | Unrelated Umbilical Cord Blood (UBC)Transplantation | completed | N/A | 34 | West Virginia UniversityOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT02809222 | Plasmatic L-AScorbic Acid in MYelodyplastic Syndroms and Controls(PLASMYC) | completed | N/A | 138 | University Hospital, ToursOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT01288222 | Selecting a Favorable KIR Donor in Unrelated HCT for AML | completed | N/A | 506 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT01807091 | Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome | completed | N/A | 17 | University of WashingtonOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT00943800 | Combined Haploidentical-Cord Blood Transplantation for Adults and Children | completed | N/A | 87 | University of ChicagoOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04617145 | Aerobic Versus Resistive Training on Functional Capacity in Acute Myeloid Leukemia | completed | N/A | 60 | Cairo UniversityOTHER | 1 | Nov 5, 2020 | clinicaltrials |
| NCT02410252 | Use Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive Therapies | completed | N/A | 25 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT04595955 | Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life | completed | N/A | 99 | Radboud University Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT00534118 | Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant | completed | N/A | 39 | Roswell Park Cancer InstituteOTHER | 1 | Aug 26, 2020 | clinicaltrials |
| NCT01869777 | Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia | completed | N/A | 102 | Wake Forest University Health SciencesOTHER | 1 | Aug 13, 2020 | clinicaltrials |
| NCT00068523 | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies | completed | N/A | 10 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT01611298 | Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR(TAR) | completed | N/A | 7 | Robert KranceOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT03907436 | The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase(NUTRIENT) | completed | N/A | 30 | University of California, IrvineOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT02487069 | Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy | completed | N/A | 876 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT00342316 | Reduced Intensity Conditioning Transplantation Versus Standard of Care in Acute Myeloid Leukemia | completed | N/A | 340 | Vastra Gotaland RegionOTHER_GOV | 9 | Jan 27, 2020 | clinicaltrials |
| NCT00014235 | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies | completed | N/A | 160 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 21, 2020 | clinicaltrials |
| NCT00001623 | Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia | completed | N/A | 41 | National Heart, Lung, and Blood Institute (NHLBI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT02719821 | Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation | completed | N/A | 17 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT02955043 | Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery | completed | N/A | 39 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT00856388 | Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders | completed | N/A | 62 | Roswell Park Cancer InstituteOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT03442452 | AML Electronic Decision Aid | completed | N/A | 20 | Duke UniversityOTHER | 1 | Oct 15, 2019 | clinicaltrials |
| NCT00005799 | Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | completed | N/A | 55 | Fred Hutchinson Cancer CenterOTHER | 2 | Sep 10, 2019 | clinicaltrials |
| NCT00179764 | Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) | completed | N/A | 68 | Ann & Robert H Lurie Children's Hospital of ChicagoOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT01519596 | Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy | completed | N/A | 70 | Wake Forest University Health SciencesOTHER | 1 | Aug 16, 2019 | clinicaltrials |
| NCT02602587 | Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients(OXYLAM) | completed | N/A | 37 | University Hospital, ToulouseOTHER | 1 | May 13, 2019 | clinicaltrials |
| NCT01499147 | Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies | completed | N/A | 100 | University of Illinois at ChicagoOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03726944 | The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients | completed | N/A | 128 | Arizona State UniversityOTHER | 1 | Nov 1, 2018 | clinicaltrials |
| NCT00789256 | Low Dose Melphalan and Bortezomib for AML and High-Risk MDS | completed | N/A | 26 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Oct 24, 2018 | clinicaltrials |
| NCT02877277 | Epigenetics, Vitamin C and Abnormal Hematopoiesis - Pilot Study(EVITA-Pilot) | completed | N/A | 20 | Rigshospitalet, DenmarkOTHER | 1 | Sep 24, 2018 | clinicaltrials |
| NCT00453206 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases | completed | N/A | 66 | Wake Forest University Health SciencesOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT01872819 | Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay | completed | N/A | 16 | University of WashingtonOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT01053494 | Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer | completed | N/A | 80 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT02101983 | Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) | completed | N/A | 11 | University of RochesterOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT01804101 | Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia | completed | N/A | 48 | Fred Hutchinson Cancer CenterOTHER | 1 | May 25, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Oct 3, 2022source: clinicaltrials